Brain surgeons treating Chiari malformation may be performing an unnecessary additional procedure that adds operative time without improving patient outcomes. This finding challenges a decades-old surgical practice where many neurosurgeons routinely open the protective brain covering during decompression surgery.
A randomized controlled trial involving 190 adults with Chiari I malformation and syringomyelia compared two surgical approaches: standard posterior fossa decompression alone versus decompression combined with duraplasty, which involves opening and patching the dura mater surrounding the brain. After 24 months, both groups showed equivalent improvements in headache severity, neurological symptoms, and quality of life measures. Syrinx reduction occurred similarly in both treatment arms, with no significant differences in complication rates.
This represents the first definitive clinical trial evidence addressing a longstanding surgical debate. Chiari malformation affects roughly 1 in 1,000 people, causing the brain's cerebellar tonsils to herniate through the skull base, often creating fluid-filled cavities in the spinal cord called syringomyelia. While decompression surgery reliably improves symptoms, the added duraplasty step has remained controversial, with some surgeons considering it essential and others viewing it as potentially harmful.
The findings suggest a more conservative surgical approach may be optimal, reducing operative complexity while maintaining therapeutic effectiveness. However, this single-institution study requires validation across diverse surgical centers and patient populations. The results may not apply to pediatric cases or patients with more severe anatomical variants. For the estimated 100,000 Americans living with symptomatic Chiari malformation, this evidence supports streamlined surgical decision-making that prioritizes proven benefit over traditional practice patterns.